Business Insider

2021-11-30 14:11:06 How bad are the Omicron variant symptoms?

The South African doctor who first reported the new variant said people with the Omicron variant have 'extremely mild' symptoms and haven't had to be hospitalized yet.

On the vaccine front, White House cheif medical officer Dr. Anthony Fauci says it looks like the Omicron variant could evade some antibodies from COVID-19 vaccines, but they still offer the best chance of protection.

Meanwhile, BioNTech has already started developing a new Omicron version of its COVID-19 vaccine, as it doesn’t want to “waste any time.”

For more stories like this, subscribe to @Insider here on Telegram. Open / Comment

2021-11-29 19:28:12 Jack Dorsey has stepped down from his role as CEO of Twitter, the company said Monday. He became Twitter CEO in 2006, and will remain a member of the Board until 2022.

CTO Parag Agrawal is Dorsey's successor, Twitter said. Agrawal has been with Twitter for more than a decade and has been its CTO since 2017.

"I want you all to know that this was my decision and I own it," Dorsey wrote to his employees. "It was a tough one for me." Read more from the letter announcing his resignation.

And for more stories like this, subscribe to @BusinessInsider here on Telegram. Open / Comment

2021-11-23 16:19:52 President Biden authorized the release of 50 million barrels of oil, hoping to tame a sharp spike in gas prices, the White House announced Tuesday.

With Jerome Powell’s second term, markets are betting the Fed will be more aggressive on inflation.

And in other economy news, Afghanistan’s financial system is on the brink of collapse, the UN warned. The US is still keeping nearly $10 billion of its reserves frozen.

Read more stories like this by subscribing to @BusinessInsider here on Telegram. Open / Comment

2021-10-29 18:47:55 Facebook said Thursday it was changing its corporate name to Meta, leaning into its “meta verse” mission. But can it save Facebook from this month’s massive PR nightmare?

The company is trying to "divert the conversation from their current problems onto the metaverse, which is exciting and futuristic," according to Anne Olderog — senior partner at the consulting firm Vivaldi with 20 years of brand strategy experience.

But some experts say Facebook still has to do the "fundamental work" and win the consumer's trust back.

Meanwhile, Mark Zuckerberg said it was "ridiculous" for people to think that he changed Facebook's name because of the recent wave of backlash.

Read more on what’s happening with Meta by subscribing to @BusinessInsider here on Telegram. Open / Comment

2021-10-28 18:41:47 Shiba inu coin is up more than 7 million percent since its debut in August 2020. A crypto wallet shows an investor made an $8,000 coin purchase last year, shortly after it debuted. Today it is worth $5.7 billion.

Former President Donald Trump criticized Mark Zuckerberg, Facebook's chief executive, in a statement. Trump said the $400 million donation that Zuckerberg made to local election offices last year makes him a "criminal."

Maggie Karlin has been a living statue for nine years and a full-time one for a year – this is how much they earn.

For more stories like this, subscribe to @BusinessInsider on Telegram. Open / Comment

2021-10-25 19:58:47 Over a dozen news organizations reviewed Facebook documents leaked by whistleblower Frances Haugen, and published a flurry of reports today based on those documents, known as The Facebook Papers.

The topics range from Facebook's fading popularity with teens to failures in addressing hate speech:

@Bloomberg and The Verge reported on internal company documents appearing to show that Facebook has been losing traction with teen users and desperately trying to recapture the market.

@FinancialTimes reported that Facebook employees urged management not to make moderation exceptions for politicians and celebrities.

The New York Times reported on internal documents appearing to show how the company grappled with whether to keep or get rid of the "like" and "share" buttons.

Here’s more on the stories revealing new information about Facebook.

For more stories like this, subscribe to @BusinessInsider on Telegram. Open / Comment

2021-10-14 18:17:02 Dozens of technical women at Microsoft wrote internal emails discussing gender discrimination, and are calling on management to fix disparities in salaries, rewards, and promotions.

Many women used the email thread to express their belief that men generally make more than women across Microsoft in both base compensation and bonuses. A spreadsheet of more than 1,200 Microsoft employees' salaries was also shared in the email chain.

For more stories like this, subscribe to @BusinessInsider on Telegram. Open / Comment

2021-10-11 21:24:37 Business Insider pinned a photo Open / Comment

2021-10-11 17:49:14 What is it about 'Squid Game'? The over-the-top drama series is already making a cultural impact across the globe, with memes on social media, searches for retro-looking tracksuits resembling the ones worn on the show up 97%, according to Lyst Insights. Here’s how the series became so popular.

Facebook had a bruising few weeks of controversy, but Mark Zuckerberg went out of his way not to show it. From whistleblower bashing to the biggest tech meltdown in years, Facebook employees describe unprecedented turmoil.

Having imposter syndrome when you're the boss is hard. But research shows it may make you better at your job.

For more stories like this, subscribe to @BusinessInsider on Telegram. Open / Comment

2021-10-01 15:52:16 A COVID-19 pill developed by Merck and Ridgeback halved the likelihood of death or hospitalization from the virus in a study, interim results suggest.

The companies said Friday morning that they would apply for emergency approval from the Food and Drug Administration (FDA) "as soon as possible," adding that they had stopped recruitment into their study early "due to these positive results."

If they get authorization, their drug, Molnupiravir, would be the first antiviral pill on the market that's designed specifically to treat COVID-19 patients.

Photo: Merck.

Subscribe to @BusinessInsider on Telegram for more stories like this. Open / Comment